Author

Oitak Wong

Observed names: Oitak (Allen) Wong, Oitak Allen Wong

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Bristol-Myers Squibb (United States)

OpenAlex ID: A5011830949

Quantification of Tau in Cerebrospinal Fluid by Immunoaffinity Enrichment and Tandem Mass Spectrometry

2014 · Thomas McAvoy, Michael E Lassman, et al. · Clinical Chemistry · 75

Practical Immunoaffinity-Enrichment LC-MS for Measuring Protein Kinetics of Low-Abundance Proteins

2014 · Michael E Lassman, Thomas McAvoy, et al. · Clinical Chemistry · 34

A clinical biomarker assay to quantitate CXCL9 in human serum

2025 · Lucia Franco-Dilone, Oitak Allen Wong, et al. · BioTechniques · 1

Preclinical development of MK‐2214 a novel antibody targeting pS413 tau for the treatment of Alzheimer’s Disease

2025 · Jonathan A Sugam, Seth Robey, et al. · Alzheimer s & Dementia · 1

Abstract 1573: A clinical biomarker assay to quantitate MIP-1a in human serum

2018 · Li Chin Wong, Oitak Wong, et al. · Cancer Research

P2‐036: Development and analytical validation of a novel assay for detection of human Aβ1‐42 peptide in human CSF

2012 · Flora Berisha, Jill Dunty, et al. · Alzheimer s & Dementia

P2‐037: Development and analytical validation of a novel assay for measurement of total tau in human CSF

2012 · Jill Dunty, Flora Berisha, et al. · Alzheimer s & Dementia

P2‐008: Modified Aβ42 peptides as immunoassay calibrators improve the measurement of native Aβ42 peptides in clinical samples

2012 · Flora Berisha, Oitak (Allen) Wong, et al. · Alzheimer s & Dementia

P2‐217: Fit for purpose Clinical validation of a multiplex immunoassay for the measurement of Tau, p‐Tau and Abeta 42

2011 · Flora Berisha, Oitak (Allen) Wong, et al. · Alzheimer s & Dementia

Works count: 9

Citation count: 111

H-index: 2

I10-index: 2